Healthcare AI Stuff
Hot announcements of the week
The U.S. Food and Drug Administration (FDA) has approved a new AI-powered system to help doctors diagnose skin cancer. The system, called Affirma, is the first AI-powered device to be approved by the FDA for this purpose.
A new study has found that virtual reality (VR) can effectively treat chronic pain. The study, published in the journal Pain, found that VR can help reduce pain and improve the quality of life for people with chronic pain.
A new study has found that wearable devices can help to improve the management of diabetes. The study, published in Diabetes Care, found that wearable devices can help people with diabetes track their blood sugar levels and make better lifestyle choices.
A new study has found that telemedicine can be an effective way to deliver mental health care. The study, published in the journal JAMA Psychiatry, found that telemedicine can be just as effective as in-person therapy for treating mental health conditions.
Recent Healthcare AI Investments
Hippocratic AI raised $50 million in a seed round led by Andreessen Horowitz and General Catalyst. The company is developing an AI platform to help patients understand their medical bills and insurance coverage.
Enveda Biosciences raised $45 million in a Series B round led by Deerfield Management. The company is developing AI-powered drugs from plants.
Orbital Therapeutics raised $35 million in a Series A round led by Third Rock Ventures. The company is developing RNA-based medicines for cancer and other diseases.
Noah Medical raised $25 million in a Series A round led by 8VC. The company is developing a medical robot to help surgeons perform minimally invasive procedures.
K Health raised $20 million in a Series C round led by Thrive Capital. The company is developing an AI-powered health app to help patients diagnose and treat their conditions.